Aspire Biopharma Holdings, Inc. (ASBP) Technical Analysis

🔺 Technical Setup

📊 Technical Summary

The latest close for Aspire Biopharma Holdings, Inc. (ASBP) came in at 0.22 (-9.30%). The chart is still trading below both the 50-day and 200-day moving averages, leaving the overall technical backdrop under pressure for now. 20-day momentum is notably weak at -78.09%; price is trading in the lower part of its roughly 52-week range (0.20–28.24); and ATR14 volatility is elevated at roughly 55.78% of price. RSI(14) sits near 31.4, which signals relatively weak momentum conditions. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram remains negative, suggesting momentum is still on the softer side. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. Pattern signals currently detected: pat_inverse_hs. On the upside, 1.07 is the nearest resistance area. A cleaner push through that zone would improve continuation potential. Fundamentals snapshot: Revenue: 6,202 · Net income: -24.48M · EPS (basic): -0.04. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

Explore more